292 related articles for article (PubMed ID: 7366992)
1. [Indomethacin therapy of children with nephrogenic diabetes insipidus].
Túri S; László A; Mérth I
Orv Hetil; 1980 Feb; 121(6):337-40. PubMed ID: 7366992
[No Abstract] [Full Text] [Related]
2. Indomethacin for nephrogenic diabetes insipidus in a four-week-old infant.
Rosen GH; Klein-Schwartz W; Medani CR
Clin Pharm; 1986 Mar; 5(3):254-6. PubMed ID: 3956132
[No Abstract] [Full Text] [Related]
3. Mechanism of action of indomethacin in tubular defects.
Usberti M; Pecoraro C; Federico S; Cianciaruso B; Guida B; Romano A; Grumetto L; Carbonaro L
Pediatrics; 1985 Mar; 75(3):501-7. PubMed ID: 3856211
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin-resistant nephrogenic diabetes insipidus. A result of amphotericin B therapy.
Barbour GL; Straub KD; O'Neal BL; Leatherman JW
Arch Intern Med; 1979 Jan; 139(1):86-8. PubMed ID: 760689
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of a defect in the formation of adenosine 3',5'-monophosphate in vasopressin-resistant diabetes insipidus.
Bell NH; Clark CM; Avery S; Sinha T; Trygstad CW; Allen DO
Pediatr Res; 1974 Apr; 8(4):223-30. PubMed ID: 4362729
[No Abstract] [Full Text] [Related]
6. [Studies on diabetes insipidus in children. I. Sensitivity to ADH].
Balsan S; Mouzet-Mazza MT; Loirat C; Fellot C; Royer P
Arch Fr Pediatr; 1971 Apr; 28(4):353-63. PubMed ID: 5087582
[No Abstract] [Full Text] [Related]
7. [Central and nephrogenic diabetes insipidus. Use of the intravenous DDAVP test].
Vanelli M; Bernasconi S; Giovannelli G
Minerva Pediatr; 1977 Mar; 29(10):721-5. PubMed ID: 875941
[No Abstract] [Full Text] [Related]
8. Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors.
Libber S; Harrison H; Spector D
J Pediatr; 1986 Feb; 108(2):305-11. PubMed ID: 3080575
[TBL] [Abstract][Full Text] [Related]
9. The differential diagnosis of nephrogenic diabetes insipidus.
Oetliker O; Bretscher D
Schweiz Rundsch Med Prax; 1975 Aug; 64(34):1090-4. PubMed ID: 1161756
[No Abstract] [Full Text] [Related]
10. Coexistence of distal renal tubular acidosis and nephrogenic diabetes insipidus in two patients: implications for the pathogenesis of distal renal tubular acidosis.
Folami AO; Balfe JW; Robson WL; Halperin ML; Stinebaugh BJ
Clin Invest Med; 1978; 1(2):105-9. PubMed ID: 757504
[No Abstract] [Full Text] [Related]
11. Evaluation of carbamazepine and clofibrate antidiuretic effect by mannitol osmolar clearance.
Simon J; Zamora I; Mendizabal S; Bartolome V
Helv Paediatr Acta; 1979 Sep; 34(4):329-38. PubMed ID: 521299
[No Abstract] [Full Text] [Related]
12. [Electrolyte excretion and renal concentrating ability after inhibition of prostaglandin synthesis with indomethacin. Studies in healthy subjects and in patients with hereditary central diabetes insipidus].
Maschler CL; Düsing R; Kramer HJ
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1327-31. PubMed ID: 611846
[No Abstract] [Full Text] [Related]
13. Indomethacin treatment for polyhydramnios and subsequent infantile nephrogenic diabetes insipidus.
Smith LG; Kirshon B; Cotton DB
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 1):98-9. PubMed ID: 2197875
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus.
Allen HM; Jackson RL; Winchester MD; Deck LV; Allon M
Arch Intern Med; 1989 May; 149(5):1123-6. PubMed ID: 2719505
[TBL] [Abstract][Full Text] [Related]
15. [Long-term course of 6 boys with congenital nephrogenic diabetes insipidus].
Kaulitz R; Brodehl J
Klin Padiatr; 1989; 201(6):425-30. PubMed ID: 2601280
[TBL] [Abstract][Full Text] [Related]
16. The effect of inhibition of prostaglandin synthesis on free water and osmolar clearances in patients with hereditary nephrogenic diabetes insipidus.
Blachar Y; Zadik Z; Shemesh M; Kaplan BS; Levin S
Int J Pediatr Nephrol; 1980 Mar; 1(1):48-52. PubMed ID: 7343530
[No Abstract] [Full Text] [Related]
17. Effect of hydrochlorothiazide and indomethacin treatment on renal function in nephrogenic diabetes insipidus.
Jakobsson B; Berg U
Acta Paediatr; 1994 May; 83(5):522-5. PubMed ID: 8086732
[TBL] [Abstract][Full Text] [Related]
18. Diuretic and antidiuretic effects of furosemide before and during the early period of pitressin therapy in diabetes insipidus.
Radó JP; Takó J; Szabó T; Bános C
Endokrinologie; 1969; 54(1):26-35. PubMed ID: 5358572
[No Abstract] [Full Text] [Related]
19. Concentrating power of the kidney after five years of pitressin-tannate therapy in a patient with diabetes insipidus untreated for 13 years. (Investigations during intravenous administration of hypertonic sodium chloride, lysine-vasopressin, clopamide and furosemide).
Radó JP; Marosi J; Takó J
Endokrinologie; 1970; 55(5):359-65. PubMed ID: 5439569
[No Abstract] [Full Text] [Related]
20. Patterns of anti-diuretic function in diabetes insipidus caused by histiocytosis X.
Helbock H; Krivit W; Nesbit ME
J Lab Clin Med; 1971 Aug; 78(2):194-202. PubMed ID: 5567562
[No Abstract] [Full Text] [Related]
[Next] [New Search]
